Wednesday, 29 August 2012

Ampion

Ampion™ for Inflammation Ampion™ is an NME being developed as a non-steroidal injection and oral drug for the treatment of diseases involving inflammation. As a mimic of a naturally occurring human molecule, Ampion™ is predicted to have an excellent human safety profile. Ampion™ selectively reduced inflammatory and immune responses in a variety of in vitro and ex vivo investigations that included human cells and tissue. Oral Ampion™ significantly reduced neurological symptoms without toxicity in an in vivo model of inflammatory and immune-mediated CNS disease. Ampion™ appears to be suitable for the treatment of a variety of chronic inflammatory and immune-mediated diseases including arthritis, allergic conjunctivitis and rhinitis, inflammatory respiratory diseases and neurodegenerative CNS diseases.

No comments:

Post a Comment